Drug Type Recombinant polypeptide |
Synonyms NCP 101, NCP101 |
Target |
Mechanism GPCR modulators(G-protein coupled receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Skin Diseases | Preclinical | KR | 01 Nov 2023 |